BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28602692)

  • 61. The role of catastrophizing in sickle cell disease--the PiSCES project.
    Citero Vde A; Levenson JL; McClish DK; Bovbjerg VE; Cole PL; Dahman BA; Penberthy LT; Aisiku IP; Roseff SD; Smith WR
    Pain; 2007 Dec; 133(1-3):39-46. PubMed ID: 17408858
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease.
    Sarri G; Bhor M; Abogunrin S; Farmer C; Nandal S; Halloway R; Revicki DA
    Health Qual Life Outcomes; 2018 May; 16(1):99. PubMed ID: 29784054
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.
    Tripathi A; Jerrell JM; Stallworth JR
    Ann Hematol; 2011 Feb; 90(2):145-50. PubMed ID: 20714723
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
    Osunkwo I; Andemariam B; Minniti CP; Inusa BPD; El Rassi F; Francis-Gibson B; Nero A; Trimnell C; Abboud MR; Arlet JB; Colombatti R; de Montalembert M; Jain S; Jastaniah W; Nur E; Pita M; DeBonnett L; Ramscar N; Bailey T; Rajkovic-Hooley O; James J
    Am J Hematol; 2021 Apr; 96(4):404-417. PubMed ID: 33264445
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Coping strategies and laboratory pain in children with sickle cell disease.
    Gil KM; Edens JL; Wilson JJ; Raezer LB; Kinney TR; Schultz WH; Daeschner C
    Ann Behav Med; 1997; 19(1):22-9. PubMed ID: 9603674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pain Experience, Physical Function, Pain Coping, and Catastrophizing in Children With Sickle Cell Disease Who Had Normal and Abnormal Sensory Patterns.
    Hyacinth O; Machado Silva-Rodrigues F; Darezzo Rodrigues Nunes M; Carlos Lopes L; Fernandes A; Castanheira Nascimento L; Jacob E
    J Pain Symptom Manage; 2020 Dec; 60(6):1079-1091. PubMed ID: 32777458
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.
    Jonassaint CR; Parchuri E; O'Brien JA; Lalama CM; Lin J; Badawy SM; Hamm ME; Stinson J; Lalloo C; Carroll CP; Saraf SL; Gordeuk VR; Cronin R; Shah N; Lanzkron SM; Liles D; Trimnell C; Bailey L; Lawrence RH; Abebe KZ
    Br J Haematol; 2024 Mar; 204(3):1029-1038. PubMed ID: 38171495
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pain in Children and Adolescents With Sickle Cell Disease: Multidimensional Assessment.
    Abadesso C; Pacheco S; Machado MC; Finley GA
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):455-462. PubMed ID: 32925397
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuropathic pain in individuals with sickle cell disease.
    Sharma D; Brandow AM
    Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Socio-demographic characteristics and psychosocial consequences of sickle cell disease: the case of patients in a public hospital in Ghana.
    Adzika VA; Glozah FN; Ayim-Aboagye D; Ahorlu CS
    J Health Popul Nutr; 2017 Jan; 36(1):4. PubMed ID: 28143586
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Temporal relationship between daily pain and actigraphy sleep patterns in pediatric sickle cell disease.
    Fisher K; Laikin AM; Sharp KMH; Criddle CA; Palermo TM; Karlson CW
    J Behav Med; 2018 Jun; 41(3):416-422. PubMed ID: 29532199
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biopsychosocial Factors Associated With Pain and Pain-Related Outcomes in Adults and Children With Sickle Cell Disease: A Multivariable Analysis of the GRNDaD Multicenter Registry.
    Kenney MO; Wilson S; Shah N; Bortsov A; Smith WR; Little J; Lanzkron S; Kanter J; Padrino S; Owusu-Ansah A; Cohen A; Desai P; Manwani D; Rehman SSU; Hagar W; Keefe F
    J Pain; 2024 Jan; 25(1):153-164. PubMed ID: 37544393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Examining Biopsychosocial Factors in Relation to Multiple Pain Features in Pediatric Sickle Cell Disease.
    Schlenz AM; Schatz J; Roberts CW
    J Pediatr Psychol; 2016 Sep; 41(8):930-40. PubMed ID: 26869665
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Health related quality of life and perception of stigmatisation in adolescents living with sickle cell disease in Nigeria: A cross sectional study.
    Adeyemo TA; Ojewunmi OO; Diaku-Akinwumi IN; Ayinde OC; Akanmu AS
    Pediatr Blood Cancer; 2015 Jul; 62(7):1245-51. PubMed ID: 25810358
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical Ratings of Pain Sensitivity Correlate With Quantitative Measures in People With Chronic Neck Pain and Healthy Controls: Cross-Sectional Study.
    Rebbeck T; Moloney N; Azoory R; Hübscher M; Waller R; Gibbons R; Beales D
    Phys Ther; 2015 Nov; 95(11):1536-46. PubMed ID: 26023218
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association Between Borderline Personality Features and Temporal Summation of Second Pain: A Cross-Sectional Study.
    You DS; Meagher MW
    Behav Med; 2017; 43(3):208-217. PubMed ID: 28767017
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A chronology of pain and comfort in children with sickle cell disease.
    Beyer JE; Simmons LE; Woods GM; Woods PM
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):913-20. PubMed ID: 10482205
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sensitization of nociceptors and dorsal horn neurons contributes to pain in sickle cell disease.
    Uhelski ML; Simone DA
    Neurosci Lett; 2019 Jul; 705():20-26. PubMed ID: 30995520
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characteristics and potential biomarkers of adult sickle cell patients with chronic pain.
    Albo C; Kumar S; Pope M; Kidwell KM; Xu H; Bowman L; Wells L; Barrett N; Fields S; Bora P; Patel N; Kutlar A
    Eur J Haematol; 2020 Oct; 105(4):419-425. PubMed ID: 32497305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not.
    Nwenyi E; Leafman J; Mathieson K; Ezeobah N
    Int J Health Care Qual Assur; 2014; 27(6):468-81. PubMed ID: 25115050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.